explore -WSS

explore

author：entertainment 2025-09-30 00:09:00 - browse：696

Home health and hospice chain Amedisys has chosen a new corporate owner.

Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： New documents shed light on MD Anderson Cancer Institute feud

WSS

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Reports of telehealth's death have been greatly exaggerated

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Reports of telehealth's death have been greatly exaggerated

Study finds gene variants tied to breast cancer risk in Black women

knowledge

explore

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Guidelines to prevent youth baseball injuries need more muscle

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Malaria cases in Florida and Texas: Here’s what you need to know

A solution to the after

Drug repurposing or repositioning? The language matters

Investigation reveals sickle cell patients pressured into sterilizations

The high cost of giving birth even with insurance

FDA poised to publish guidelines for clinical trial diversity

hotspot

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Cue Health, Covid

Digital health: a case of mistaken identity

Dario to buy mental health app maker Twill in cash and stock deal

ASCO eve: Let’s set the table for this year's meeting

Alabama frozen embryo ruling has major implications for IVF clinics

hotspot

leisure time

explore

focus